(Q24628952)

6

object named as

Ganesh Raghu

0 references

Talmadge E King

5

object named as

Talmadge E King

0 references

author name string

Jeffrey J Swigris

1

0 references

Frederick S Wamboldt

2

0 references

Roland M du Bois

4

0 references

Kevin K Brown

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives

7

0 references

language of work or name

English

0 references

publication date

February 2010

0 references

published in

Thorax

0 references

volume

65

0 references

issue

2

0 references

page(s)

173-7

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Approaches and recommendations for estimating minimally important differences for health-related quality of life measures

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

27 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

27 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Standardized single breath normal values for carbon monoxide diffusing capacity

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Two-, six-, and 12-minute walking tests in respiratory disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Effect of encouragement on walking test performance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Reproducibility of walking test results in chronic obstructive airways disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

A maximal multistage 20-m shuttle run test to predict VO2 max.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

Spirometric standards for healthy nonsmoking adults

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3144486

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

28 November 2018

1 reference

12 December 2020

Small changes in six-minute walk distance are important in diffuse parenchymal lung disease

1 reference

12 December 2020

Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.2009.113498

1 reference

3592027

3592027

1 reference

1 reference

1 reference